JP2012532152A5 - - Google Patents

Download PDF

Info

Publication number
JP2012532152A5
JP2012532152A5 JP2012518753A JP2012518753A JP2012532152A5 JP 2012532152 A5 JP2012532152 A5 JP 2012532152A5 JP 2012518753 A JP2012518753 A JP 2012518753A JP 2012518753 A JP2012518753 A JP 2012518753A JP 2012532152 A5 JP2012532152 A5 JP 2012532152A5
Authority
JP
Japan
Prior art keywords
pyrrolo
pyrimidin
diazaspiro
oct
octane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012518753A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012532152A (ja
JP5690823B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK2010/000105 external-priority patent/WO2011003418A1/en
Publication of JP2012532152A publication Critical patent/JP2012532152A/ja
Publication of JP2012532152A5 publication Critical patent/JP2012532152A5/ja
Application granted granted Critical
Publication of JP5690823B2 publication Critical patent/JP5690823B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012518753A 2009-07-08 2010-07-08 Jak受容体およびタンパク質チロシンキナーゼ阻害薬としての複素環化合物 Expired - Fee Related JP5690823B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22394309P 2009-07-08 2009-07-08
US61/223,943 2009-07-08
PCT/DK2010/000105 WO2011003418A1 (en) 2009-07-08 2010-07-08 Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors

Publications (3)

Publication Number Publication Date
JP2012532152A JP2012532152A (ja) 2012-12-13
JP2012532152A5 true JP2012532152A5 (enExample) 2013-08-22
JP5690823B2 JP5690823B2 (ja) 2015-03-25

Family

ID=42542759

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012518753A Expired - Fee Related JP5690823B2 (ja) 2009-07-08 2010-07-08 Jak受容体およびタンパク質チロシンキナーゼ阻害薬としての複素環化合物

Country Status (9)

Country Link
US (1) US9346809B2 (enExample)
EP (1) EP2451813B1 (enExample)
JP (1) JP5690823B2 (enExample)
CN (1) CN102574857B (enExample)
AR (1) AR077465A1 (enExample)
BR (1) BR112012000422A2 (enExample)
CA (1) CA2767079A1 (enExample)
TW (1) TW201105674A (enExample)
WO (1) WO2011003418A1 (enExample)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1966202T1 (sl) 2005-12-13 2012-01-31 Incyte Corp S heteroarilom substituirani pirolo (2,3-b)piridini in pirolo (2,3-b)pirimidini kot zaviralci janus kinaze
CN106967070A (zh) 2009-05-22 2017-07-21 因塞特控股公司 作为jak抑制剂的化合物
CA2762174C (en) 2009-05-22 2018-02-20 Incyte Corporation N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
AR078012A1 (es) 2009-09-01 2011-10-05 Incyte Corp Derivados heterociclicos de las pirazol-4-il- pirrolo (2,3-d) pirimidinas como inhibidores de la quinasa janus
JP5792171B2 (ja) * 2009-09-04 2015-10-07 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 白血病を治療するための組成物および方法
WO2011029043A1 (en) * 2009-09-04 2011-03-10 Biogen Idec Ma Inc. Heteroaryl btk inhibitors
EP3715347B1 (en) 2010-03-10 2021-12-22 Incyte Holdings Corporation Piperidin-4-yl azetidine derivatives as jak1 inhibitors
PE20140146A1 (es) 2010-11-19 2014-02-06 Incyte Corp Derivados de pirrolopiridina y pirrolopirimidina sustituidos con ciclobutilo como inhibidores de jak
PL2651417T3 (pl) 2010-12-16 2017-08-31 Calchan Limited Pochodne pirolopirymidyny hamujące ASK1
RU2013136906A (ru) * 2011-01-07 2015-02-20 Лео Фарма А/С Новые производные сульфамидпиперазина в качестве ингибиторов протеинтирозинкиназы и их фармацевтическое применение
WO2012127506A1 (en) 2011-03-22 2012-09-27 Advinus Therapeutics Limited Substituted fused tricyclic compounds, compositions and medicinal applications thereof
US9187487B2 (en) 2011-05-17 2015-11-17 Principia Biopharma, Inc. Azaindole derivatives as tyrosine kinase inhibitors
TWI577676B (zh) 2011-06-20 2017-04-11 英塞特控股公司 作為jak抑制劑之吖丁啶基苯基、吡啶基或吡基羧醯胺衍生物
TW201313721A (zh) 2011-08-18 2013-04-01 Incyte Corp 作為jak抑制劑之環己基氮雜環丁烷衍生物
UA111854C2 (uk) 2011-09-07 2016-06-24 Інсайт Холдінгс Корпорейшн Способи і проміжні сполуки для отримання інгібіторів jak
EP2788000B1 (en) * 2011-12-06 2018-05-30 Merck Sharp & Dohme Corp. Pyrrolopyrimidines as janus kinase inhibitors
TW201406761A (zh) 2012-05-18 2014-02-16 Incyte Corp 做爲jak抑制劑之哌啶基環丁基取代之吡咯并吡啶及吡咯并嘧啶衍生物
EA201590053A1 (ru) * 2012-06-20 2015-08-31 Новартис Аг Модуляторы пути системы комплемента и их применение
ES2889757T3 (es) * 2012-09-06 2022-01-13 Plexxikon Inc Compuestos y procedimientos para la modulación de quinasas e indicaciones para estos
IN2015DN02008A (enExample) 2012-09-21 2015-08-14 Advinus Therapeutics Ltd
MX2015005428A (es) 2012-11-01 2015-07-21 Incyte Corp Derivados triciclicos fusionados de tiofeno como inhibidores de la cinasa janus (jak).
SG11201503695XA (en) 2012-11-15 2015-06-29 Incyte Corp Sustained-release dosage forms of ruxolitinib
JP6397831B2 (ja) 2013-03-06 2018-09-26 インサイト・ホールディングス・コーポレイションIncyte Holdings Corporation Jak阻害剤の製造方法及びその中間体
CN105189508B (zh) * 2013-03-19 2018-11-23 默沙东公司 作为janus激酶抑制剂的环烷基腈吡唑并吡啶酮
WO2014146246A1 (en) * 2013-03-19 2014-09-25 Merck Sharp & Dohme Corp. Cycloalkyl nitrile pyrazolo pyridones as janus kinase inhibitors
US9957265B2 (en) 2013-03-19 2018-05-01 Merck Sharp & Dohme Corp. N-(2-cyano heterocyclyl) pyrazolo pyridones as janus kinase inhibitors
US10059705B2 (en) 2013-03-19 2018-08-28 Merck Sharp & Dohme Corp. Acyclic cyanoethylpyrazolo pyridones as janus kinase inhibitors
UA120499C2 (uk) 2013-08-07 2019-12-26 Інсайт Корпорейшн Лікування захворювань із застосуванням лікарських форм з уповільненим вивільненням для інгібітора jak1
US9233953B2 (en) 2013-10-16 2016-01-12 Boehringer Ingelheim International Gmbh Derivatives of 4-(piperazinylcarbonyl)thiane-1, 1-dione which inhibit GlyT1
ES2871524T3 (es) 2013-12-05 2021-10-29 Pfizer Pirrolo[2,3-d]pirimidinilo, pirrolo[2,3-b]pirazinilo y pirrolo[2,3-d]piridinil acrilamidas
JP2017514832A (ja) 2014-04-30 2017-06-08 インサイト・コーポレイションIncyte Corporation Jak1抑制剤を調製する方法及びその新しい形態
WO2015184305A1 (en) 2014-05-30 2015-12-03 Incyte Corporation TREATMENT OF CHRONIC NEUTROPHILIC LEUKEMIA (CNL) AND ATYPICAL CHRONIC MYELOID LEUKEMIA (aCML) BY INHIBITORS OF JAK1
NO2721710T3 (enExample) * 2014-08-21 2018-03-31
WO2016040330A1 (en) 2014-09-09 2016-03-17 The Regents Of The University Of Michigan Thienopyrimidine and thienopyridine compounds and methods of use thereof
HK1246593A1 (zh) 2015-06-04 2018-09-14 Kura Oncology, Inc. 用於抑制menin蛋白与mll蛋白的相互作用的方法及组合物
AR104020A1 (es) 2015-06-04 2017-06-21 Kura Oncology Inc Métodos y composiciones para inhibir la interacción de menina con proteínas mill
SMT202300273T1 (it) 2016-03-16 2023-09-06 Kura Oncology Inc Derivati di tieno[2,3–d]pirimidina sostituiti come inibitori di menina–mll e metodi d’uso
AU2017235462B2 (en) 2016-03-16 2021-07-01 Kura Oncology, Inc. Bridged bicyclic inhibitors of menin-MLL and methods of use
JOP20190024A1 (ar) 2016-08-26 2019-02-19 Gilead Sciences Inc مركبات بيروليزين بها استبدال واستخداماتها
JP7101685B2 (ja) * 2017-01-20 2022-07-15 レオ ファーマ アクティーゼルスカブ 新規jakキナーゼ阻害剤としての二環式アミン
EP3576743B1 (en) 2017-02-03 2023-01-18 LEO Pharma A/S 5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5-azaspiro[2 5]octane-8-carboxylic acid derivatives as jak kinase inhibitors
CN117298275A (zh) 2017-03-24 2023-12-29 库拉肿瘤学公司 治疗血液系统恶性肿瘤和尤因肉瘤的方法
CN110662755A (zh) * 2017-05-23 2020-01-07 施万生物制药研发Ip有限责任公司 托法替尼的硫代氨基甲酸酯前药
US11542248B2 (en) 2017-06-08 2023-01-03 Kura Oncology, Inc. Methods and compositions for inhibiting the interaction of menin with MLL proteins
WO2019060365A1 (en) 2017-09-20 2019-03-28 Kura Oncology, Inc. SUBSTITUTED MÉNINE-MLL INHIBITORS AND METHODS OF USE
CN111566102B (zh) 2017-10-18 2023-09-08 缆图药品公司 作为激活素受体样激酶抑制剂的取代的吡咯并吡啶
KR20190043437A (ko) * 2017-10-18 2019-04-26 씨제이헬스케어 주식회사 단백질 키나제 억제제로서의 헤테로고리 화합물
FI3724196T3 (fi) * 2017-12-15 2023-01-31 Substituoituja atsetidiinidihydrotienopyridiinejä ja niiden käyttö fosfodiesteraasin estäjinä
ES2962605T3 (es) 2018-02-26 2024-03-20 Gilead Sciences Inc Compuestos de pirrolizina sustituidos como inhibidores de la replicación del VHB
HUE067471T2 (hu) 2018-03-30 2024-10-28 Incyte Corp Gennyes verejtékmirigy-gyulladás kezelése jak inhibitorok alkalmazásával
CN108456212A (zh) * 2018-05-30 2018-08-28 杨文思 一种化合物或其溶剂合物,或前体,或它们的药学上可接受的盐、药物及其用途
WO2020092015A1 (en) 2018-11-02 2020-05-07 University Of Rochester Therapeutic mitigation of epithelial infection
KR102195348B1 (ko) 2018-11-15 2020-12-24 에이치케이이노엔 주식회사 단백질 키나제 억제제로서의 신규 화합물 및 이를 포함하는 약제학적 조성물
WO2020106825A1 (en) 2018-11-20 2020-05-28 Georgetown University Compositions and methods for treating neurodegenerative, myodegenerative, and lysosomal storage disorders
KR102112336B1 (ko) * 2019-08-12 2020-05-18 에이치케이이노엔 주식회사 단백질 키나제 억제제로서의 헤테로고리 화합물
MX2022002646A (es) 2019-09-05 2022-04-26 Incyte Corp Formulacion de ruxolitinib para la reduccion de comezon en dermatitis atopica.
WO2021185238A1 (zh) * 2020-03-17 2021-09-23 江苏恒瑞医药股份有限公司 稠合二环类衍生物、其制备方法及其在医药上的应用
CN113698403B (zh) * 2020-05-21 2022-06-28 南京亘泰医药技术有限公司 (1r,4r,7r)-7-氨基-2-氮杂双环[2,2,1]庚烷衍生物及制备方法
US11833155B2 (en) 2020-06-03 2023-12-05 Incyte Corporation Combination therapy for treatment of myeloproliferative neoplasms
CN114681461A (zh) * 2020-12-28 2022-07-01 杭州邦顺制药有限公司 用于红斑狼疮治疗的化合物
CN114681460A (zh) * 2020-12-28 2022-07-01 杭州邦顺制药有限公司 用于脓毒症治疗的化合物
EP4274832A1 (en) * 2021-01-07 2023-11-15 Biogen MA Inc. Tyk2 inhibitors
CN117157293A (zh) * 2021-03-16 2023-12-01 怡诺安有限公司 作为蛋白激酶抑制剂的杂环化合物的新型盐及其用途
EP4310085A4 (en) * 2021-03-16 2025-09-24 Hk Inno N Corp NOVEL SALTS OF HETEROCYCLIC COMPOUND AS PROTEIN KINASE INHIBITOR AND USES THEREOF
CN116514844A (zh) * 2022-01-20 2023-08-01 思路迪生物医药(上海)有限公司 一类噻吩并嘧啶类衍生物及其作为泛kras突变抑制剂的用途
AU2024253757A1 (en) * 2023-04-07 2025-10-16 Biogen Ma Inc. 1h-pyrrolo[2,3-b]pyridin-4-yl]-2-oxopyrrolidine-3-carbonitrile derivatives as tyrosine kinase 2 (tyk2) inhibitors for the treatment of inflammatory diseases
AU2024279063A1 (en) * 2023-06-02 2025-12-18 Animol Discovery, Inc. Inhibitors of canine janus kinase and uses thereof

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA005852B1 (ru) 1998-06-19 2005-06-30 Пфайзер Продактс Инк. ПИРРОЛО[2,3-d]ПИРИМИДИНЫ
PA8474101A1 (es) * 1998-06-19 2000-09-29 Pfizer Prod Inc Compuestos de pirrolo [2,3-d] pirimidina
EA006227B1 (ru) 1999-12-10 2005-10-27 Пфайзер Продактс Инк. СОЕДИНЕНИЯ ПИРРОЛО[2,3-d]ПИРИМИДИНА
AU2002336462A1 (en) 2001-09-06 2003-03-24 Millennium Pharmaceuticals, Inc. Piperazine and homopiperazine compounds
JP4768265B2 (ja) 2002-10-15 2011-09-07 シンタ ファーマシューティカルズ コーポレーション 新規化合物
SE0301372D0 (sv) 2003-05-09 2003-05-09 Astrazeneca Ab Novel compounds
NZ590160A (en) 2003-11-21 2012-07-27 Array Biopharma Inc AKT protein kinase inhibitors
JP2007512316A (ja) 2003-11-25 2007-05-17 ファイザー・プロダクツ・インク アテローム性動脈硬化症の治療方法
KR20060096153A (ko) 2003-12-17 2006-09-07 화이자 프로덕츠 인코포레이티드 이식 거부 치료용 피롤로[2,3-d]피리미딘 화합물
JP4926943B2 (ja) 2004-04-13 2012-05-09 シンタ ファーマシューティカルズ コーポレーション Il−12産生を阻害する二塩
AR054416A1 (es) 2004-12-22 2007-06-27 Incyte Corp Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas.
JP4652826B2 (ja) 2005-01-14 2011-03-16 タッチパネル・システムズ株式会社 情報入力装置
ZA200707342B (en) 2005-02-03 2009-03-25 Vertex Pharma Pyrrolopyrimidines useful as inhibitors of protein kinase
WO2006091450A1 (en) 2005-02-18 2006-08-31 Lexicon Genetics Incorporated 4-piperidin-1-yl-7h-pyrrolo[2,3-d]pyrimidine compounds
JP2008545660A (ja) 2005-05-20 2008-12-18 バーテックス ファーマシューティカルズ インコーポレイテッド プロテインキナーゼ阻害剤として有用なピロロピリジン化合物
CN102127078A (zh) 2005-07-14 2011-07-20 安斯泰来制药株式会社 Janus激酶3的杂环类抑制剂
MX2008011559A (es) 2006-03-11 2008-11-25 Vernalis R&D Ltd Derivados de pirrolopirimidina utilizados como inhibidores de hsp90.
SG170828A1 (en) 2006-04-05 2011-05-30 Vertex Pharmaceuticals Inc Us Deazapurines useful as inhibitors of janus kinases
US20080076924A1 (en) * 2006-06-30 2008-03-27 Patrick Betschmann Piperazines as P2X7 antagonists
AU2008240188A1 (en) 2007-04-13 2008-10-23 Supergen, Inc. Axl kinase inhibitors useful for the treatment of cancer or hyperproliferative disorders
DK2188289T3 (en) * 2007-08-08 2016-01-25 Lexicon Pharmaceuticals Inc (7H-Pyrrolo [2,3-D] pyrimidin-4-yl) -piperazines as kinase inhibitors for the treatment of cancer and inflammation
EP2242755B1 (en) * 2008-01-08 2012-09-12 Array Biopharma, Inc. Pyrrolopyridines as kinase inhibitors

Similar Documents

Publication Publication Date Title
JP2012532152A5 (enExample)
JP5690823B2 (ja) Jak受容体およびタンパク質チロシンキナーゼ阻害薬としての複素環化合物
JP5576802B2 (ja) C−Metチロシンキナーゼ介在疾患の治療用のイミダゾ[1,2−b]ピリダジン誘導体
KR101168625B1 (ko) 티아졸 유도체
AU2007309237B2 (en) Triazolo-pyridazine protein kinase modulators
JP5152922B2 (ja) プロテインキナーゼを阻害するためのピラゾロ[1,5−a]ピリミジン誘導体の使用およびプロテインキナーゼを阻害する方法
US8461162B2 (en) Pyrazolo[1,5-a]pyrimidine derivatives
US8895581B2 (en) 1H-imidazo[4,5-c]quinolines
US20200383963A1 (en) P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshd
JP2021506889A5 (enExample)
JP2021506816A5 (enExample)
CN106535890A (zh) 5‑取代的吲唑‑3‑羧酰胺及其制备和应用
JP2010526120A (ja) Pi3k脂質キナーゼ阻害剤としての置換イミダゾピリダジン
US10189854B2 (en) Substituted pyrimidine compounds
CN101321756A (zh) 用作细胞周期蛋白依赖性激酶抑制剂的新的吡唑并嘧啶化合物
UA119667C2 (uk) Гетероарильні інгібітори syk
CN102341400A (zh) 用作激酶抑制剂的吡咯并嘧啶化合物
JP2013533868A5 (enExample)
CN101558070A (zh) 三唑并哒嗪蛋白激酶调节剂
US10342786B2 (en) P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
CN101990401A (zh) 双药效团-pde4-毒蕈碱拮抗剂
JP2014501772A5 (enExample)
US20160108049A1 (en) Novel Phthalazinone-Pyrrolopyrimidinecarboxamide Derivatives
EP2379523A1 (en) 4, 6-disubstituted 2-amino-pyrimidines as histamine h4 receptor modulators
KR102592845B1 (ko) 6H-티에노[2,3-e][1,2,4]트리아졸로[3,4-c][1,2,4]트리아제핀 유도체